Panos Zanos

7.1k total citations · 4 hit papers
71 papers, 4.8k citations indexed

About

Panos Zanos is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Biological Psychiatry. According to data from OpenAlex, Panos Zanos has authored 71 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Cellular and Molecular Neuroscience, 36 papers in Pharmacology and 30 papers in Biological Psychiatry. Recurrent topics in Panos Zanos's work include Treatment of Major Depression (33 papers), Tryptophan and brain disorders (30 papers) and Neuroscience and Neuropharmacology Research (22 papers). Panos Zanos is often cited by papers focused on Treatment of Major Depression (33 papers), Tryptophan and brain disorders (30 papers) and Neuroscience and Neuropharmacology Research (22 papers). Panos Zanos collaborates with scholars based in United States, United Kingdom and Cyprus. Panos Zanos's co-authors include Todd D. Gould, Polymnia Georgiou, Carlos A. Zarate, Ruin Moaddel, Craig J. Thomas, Patrick J. Morris, Edson X. Albuquerque, Jaclyn N. Highland, Scott M. Thompson and Lace M. Riggs and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Neuroscience.

In The Last Decade

Panos Zanos

68 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NMDAR inhibition-independent antidepressant actions of ketamine metabolites

2016 1.1k citations Panos Zanos, Ruin Moaddel et al. profile →
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms

2018 816 citations Panos Zanos, Ruin Moaddel et al. profile →
Mechanisms of ketamine action as an antidepressant

2018 748 citations Panos Zanos, Todd D. Gould Molecular Psychiatry profile →
The impact of estradiol on serotonin, glutamate, and dopamine systems

2024 41 citations Panos Zanos, Polymnia Georgiou et al. Frontiers in Neuroscience profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Panos Zanos United States	29	2.7k	2.2k	2.1k	670	649	71	4.8k
Polymnia Georgiou United States	24	1.7k 0.6×	1.4k 0.6×	1.5k 0.7×	502 0.7×	505 0.8×	45	3.4k
Masaaki Iwata Japan	19	1.5k 0.6×	2.4k 1.1×	1.8k 0.8×	1.3k 1.9×	955 1.5×	63	4.9k
Chadi G. Abdallah United States	39	2.2k 0.8×	1.9k 0.9×	1.4k 0.7×	998 1.5×	437 0.7×	112	5.5k
Boyoung Lee South Korea	24	2.0k 0.8×	2.0k 0.9×	2.5k 1.2×	784 1.2×	995 1.5×	55	4.9k
Dan A. Oren United States	30	2.5k 0.9×	2.1k 0.9×	1.9k 0.9×	617 0.9×	564 0.9×	73	5.5k
Ioline D. Henter United States	40	1.9k 0.7×	2.0k 0.9×	1.2k 0.6×	599 0.9×	605 0.9×	81	4.8k
Paul J. Carlson United States	17	2.2k 0.8×	1.9k 0.8×	1.4k 0.7×	527 0.8×	356 0.5×	24	3.7k
Angela Cappiello United States	12	2.3k 0.9×	1.9k 0.9×	1.7k 0.8×	497 0.7×	443 0.7×	14	3.8k
Jaskaran Singh United States	31	5.2k 2.0×	4.1k 1.8×	2.5k 1.2×	765 1.1×	653 1.0×	94	8.1k
Nancy Diazgranados United States	25	2.6k 1.0×	2.2k 1.0×	1.3k 0.6×	354 0.5×	348 0.5×	79	4.5k

Countries citing papers authored by Panos Zanos

Since Specialization

Citations

This map shows the geographic impact of Panos Zanos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Panos Zanos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Panos Zanos more than expected).

Fields of papers citing papers by Panos Zanos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Panos Zanos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Panos Zanos. The network helps show where Panos Zanos may publish in the future.

Co-authorship network of co-authors of Panos Zanos

This figure shows the co-authorship network connecting the top 25 collaborators of Panos Zanos. A scholar is included among the top collaborators of Panos Zanos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Panos Zanos. Panos Zanos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zanos, Panos, et al.. (2024). The impact of estradiol on serotonin, glutamate, and dopamine systems. Frontiers in Neuroscience. 18. 1348551–1348551. 41 indexed citations breakdown →

Zanos, Panos, et al.. (2024). From Viral Infections to Alzheimer's Disease: Unveiling the Mechanistic Links Through Systems Bioinformatics. The Journal of Infectious Diseases. 230(Supplement_2). S128–S140. 5 indexed citations

Voskarides, Konstantinos, et al.. (2024). Investigating the shared genetic basis and causal relationships between mucosa-associated lymphoid tissue inflammation and psychiatric disorders. Frontiers in Psychiatry. 15. 1379922–1379922.

Chatzittofis, Andreas, et al.. (2024). Ketamine and Hydroxynorketamine as Novel Pharmacotherapies for the Treatment of Opioid Use Disorders. Biological Psychiatry. 97(6). 563–579. 3 indexed citations

Christodoulou, Christiana C., et al.. (2024). Transcriptomic analysis reveals sex-specific patterns in the hippocampus in Alzheimer’s disease. Frontiers in Endocrinology. 15. 1345498–1345498. 7 indexed citations

Christodoulou, Christiana C., et al.. (2023). Unraveling the transcriptomic signatures of Parkinson’s disease and major depression using single-cell and bulk data. Frontiers in Aging Neuroscience. 15. 10 indexed citations

Moaddel, Ruin, Panos Zanos, Cristan Farmer, et al.. (2022). Comparative metabolomic analysis in plasma and cerebrospinal fluid of humans and in plasma and brain of mice following antidepressant-dose ketamine administration. Translational Psychiatry. 12(1). 179–179. 20 indexed citations

Bonaventura, Jordi, Juan L. Gomez, Sherry Lam, et al.. (2022). Target deconvolution studies of (2R,6R)-hydroxynorketamine: an elusive search. Molecular Psychiatry. 27(10). 4144–4156. 27 indexed citations

Osman, Aya, Simone Zuffa, Gemma Walton, et al.. (2021). Post-weaning A1/A2 β-casein milk intake modulates depressive-like behavior, brain μ-opioid receptors, and the metabolome of rats. iScience. 24(9). 103048–103048. 13 indexed citations

10.

Elmer, Gregory I., Jenica D. Tapocik, Cheryl L. Mayo, Panos Zanos, & Todd D. Gould. (2020). Ketamine metabolite (2R,6R)-hydroxynorketamine reverses behavioral despair produced by adolescent trauma. Pharmacology Biochemistry and Behavior. 196. 172973–172973. 12 indexed citations

11.

Highland, Jaclyn N., Panos Zanos, Polymnia Georgiou, & Todd D. Gould. (2019). Group II metabotropic glutamate receptor blockade promotes stress resilience in mice. Neuropsychopharmacology. 44(10). 1788–1796. 42 indexed citations

12.

Georgiou, Polymnia, Panos Zanos, Carleigh Jenne, & Todd D. Gould. (2019). Sex-Specific Involvement of Estrogen Receptors in Behavioral Responses to Stress and Psychomotor Activation. Frontiers in Psychiatry. 10. 81–81. 21 indexed citations

13.

Krimmel, Samuel R., Panos Zanos, Polymnia Georgiou, Luana Colloca, & Todd D. Gould. (2019). Classical conditioning of antidepressant placebo effects in mice. Psychopharmacology. 237(1). 93–102. 8 indexed citations

14.

Georgiou, Polymnia, Lisa A. Brenner, Lena Brundin, et al.. (2017). Animal models to improve our understanding and treatment of suicidal behavior. Translational Psychiatry. 7(4). e1092–e1092. 64 indexed citations

15.

Martynhak, Bruno Jacson, Panos Zanos, Polymnia Georgiou, et al.. (2017). Transient anhedonia phenotype and altered circadian timing of behaviour during night-time dim light exposure in Per3−/− mice, but not wildtype mice. Scientific Reports. 7(1). 40399–40399. 19 indexed citations

16.

Zanos, Panos, Polymnia Georgiou, Susanna M.O. Hourani, et al.. (2016). Emotional Impairment and Persistent Upregulation of mGlu₅Receptor following Morphine Abstinence: Implications of an mGlu₅-MOPr Interaction. The International Journal of Neuropsychopharmacology. 19(7). pyw011–pyw011. 23 indexed citations

17.

Zanos, Panos, Sean C. Piantadosi, Hui‐Qiu Wu, et al.. (2015). The Prodrug 4-Chlorokynurenine Causes Ketamine-Like Antidepressant Effects, but Not Side Effects, by NMDA/GlycineB-Site Inhibition. Journal of Pharmacology and Experimental Therapeutics. 355(1). 76–85. 93 indexed citations

18.

Chao, Mu‐Rong, Domniki Fragou, Panos Zanos, et al.. (2014). Epigenetically modified nucleotides in chronic heroin and cocaine treated mice. Toxicology Letters. 229(3). 451–457. 16 indexed citations

19.

Fragou, Domniki, Panos Zanos, Sofia Kouidou, et al.. (2013). Effect of chronic heroin and cocaine administration on global DNA methylation in brain and liver. Toxicology Letters. 218(3). 260–265. 33 indexed citations

20.

Zanos, Panos, Polymnia Georgiou, Susanna M.O. Hourani, et al.. (2013). The Oxytocin Analogue Carbetocin Prevents Emotional Impairment and Stress-Induced Reinstatement of Opioid-Seeking in Morphine-Abstinent Mice. Neuropsychopharmacology. 39(4). 855–865. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact